By Jonathan Baktari, MD, CEO of US Drug Test Centers Are your employees sober while they’re on the clock? Concerning statistics suggest that more professionals are testing positive for illicit drugs while simultaneously, fewer companies are conducting...
Featured posts
All posts
DOT Withdraws Direct Final Rule in Response to Negative Feedback
NDASA is pleased to announce that our efforts have been successful in having the Department of Transportation (DOT) withdraw its direct final rule relating to 49 CFR Part 40, "Procedures for Transportation Workplace Drug and Alcohol Testing Programs" which would have...
NDASA’s public comments on the proposed rescheduling of marijuana – Part 2
The Honorable Merrick B. Garland Attorney GeneralU.S. Department of Justice The Honorable Anne Milgram, Administrator Drug Enforcement Administration8701 Morrissette DriveSpringfield, Virginia 22152 Submitted via Electronic DocketJuly 17 , 2024 Re: Part 2 of 2 of the...
In memoriam: a tribute to Joe Plaia
The National Drug and Alcohol Screening Association and the entire drug testing industry lost one of the all-time greatest of our profession when dear friend and associate Joe Plaia of Alabama passed away July 7 at the age of 72. Joe worked for more than 30 years at...
Marijuana legalization, the DEA and harmful, unintended consequences
By Bill Current, Founder of the Current Consulting Group It’s been said that elections have consequences, including unintended consequences that can be harmful, nonetheless. The Drug Enforcement Administration (DEA), at President Biden’s direction, intends to...
Working on your business versus in your business
By Jonathan Baktari, MD, CEO of US Drug Test Centers Every successful entrepreneur has to start somewhere. If you're a business owner, then maybe you can remember wearing all the hats in the very beginning, when you were first getting your company off the ground. You...
NDASA’s public comments on the proposed rescheduling of marijuana – Part 1
The Honorable Merrick B....
How to provide comment for the DEA’s Notice of Proposed Rulemaking (NPRM) regarding the rescheduling of marijuana
Make your voice heard! You can have an impact on the U.S. Drug Enforcement Administration’s proposal to reschedule marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act by providing comment to the NPRM. The deadline for submitting...
Workforce drug test cheating surged in 2023, finds Quest Diagnostics Drug Testing Index analysis of nearly 10 million drug tests
Reprinted article courtesy of Quest Diagnostics, a leading provider of diagnostic information services. Key Findings The overall drug positivity held steady at historically high rates in 2023, while marijuana positivity continued an upward climb in the general U.S....
National Drug & Alcohol Screening Association urges protection of transportation safety amid marijuana rescheduling debate
Rescheduling marijuana to Schedule III will prevent the U.S. Department of Transportation from prohibiting active use for those in transportation safety positions. Without a safety carveout - or a clear plan to prevent this unintended consequence, the traveling public...